SR9009

SR9009 is a rev-ErbA agonist. It increases the constitutive repression of genes regulated by Rev-ErbA with a half-maximum inhibitory concentration (IC50) = 670 nM for Rev-ErbAα and IC50 = 800 nM for Rev-ErbAβ.